Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
02/2002
02/28/2002WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/28/2002US20020025961 Platelet ADP receptor inhibitors
02/28/2002US20020025949 Anti-epileptogenic agents
02/28/2002DE10040527A1 New 4-tert. butoxycarbonylamino-quinazoline derivatives, useful as intermediates for tyrosine kinase-mediated signal transduction inhibitors
02/28/2002CA2420289A1 10-aryl-11-hbenzo [b]fluorene derivatives and analogs for medicinal use
02/28/2002CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/27/2002EP1182186A2 Difluoromethyl ether derivative and process for producing the same
02/27/2002EP1181281A2 Novel carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
02/27/2002EP1181280A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
02/27/2002EP1181279A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
02/27/2002EP1181271A2 Naphthalene ureas as glucose uptake enhancers
02/27/2002EP1181266A1 Squaric acid derivatives as cell adhesion molecules
02/27/2002EP0892789B1 Irreversible inhibitors of tyrosine kinases
02/27/2002EP0724574B1 3-methoxy-2-phenylacrylic acid methyl esters
02/27/2002CN1337941A Amide derivatives
02/26/2002US6350786 Complexes significantly increase the bioavailability of poorly soluble therapeutically active compounds
02/26/2002US6350764 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
02/26/2002US6350750 Quinoline and quinazoline derivatives having corticotropin releasing factor (CRF) antagonist activity
02/26/2002US6350749 Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
02/26/2002US6350746 Benzamidine derivatives and their use as anti-coagulants
02/26/2002CA2230237C Process for preparing quinazolin-4-one derivative
02/22/2002WO2001012610A1 Method for producing 4,6-dichloropyrimidine with sulfur compounds and phosphorous compounds
02/22/2002CA2388607A1 Method for producing 4,6-dichloropyrimidine with sulfur compounds and phosphorous compounds
02/21/2002WO2002014286A1 Preparation of risperidone
02/21/2002WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors
02/21/2002WO2001068609B1 1,2,3,4-tetrahydroisoquinoline derivatives
02/21/2002WO2001042225A3 4-pyrimidinyl-n-acyl-l-phenylalanines
02/21/2002US20020022727 Method for producing ar(alk)yluraciles, novel corresponding intermediate products and method for producing said intermediate products
02/21/2002US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
02/21/2002US20020022628 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound
02/20/2002EP1180520A1 Heterocyclic carboxylic acid derivatives
02/20/2002EP1180098A1 New compounds
02/20/2002EP1180034A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography
02/20/2002EP0942905B1 3-amino-1-cyanophenyl-uracils
02/20/2002EP0863706B1 Method of controlling undesired plant growth in rice
02/20/2002EP0783307B1 Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders
02/20/2002CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
02/20/2002CN1336912A Novel propargylether derivatives
02/19/2002US6348627 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
02/19/2002US6348594 Hardening of polymers
02/19/2002US6348592 Method of making dihydroperimidine squaraine compounds
02/19/2002US6348587 Purine or pyrimidine base derivatives; anticancer, antitumor and antiproliferative agents; treating hiv and hepatitis
02/19/2002US6348474 Compounds as antidiabetic agents
02/19/2002US6348471 Pyrimidyl oxyphenylacetic acid derivatives
02/19/2002US6348463 Phenylalanine derivatives
02/19/2002US6348244 Liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element
02/14/2002WO2002012224A2 Bicyclic compounds as h3 receptor ligands
02/14/2002WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials
02/14/2002WO2002012198A2 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
02/14/2002WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/14/2002WO2002012165A1 (poly)ethereal ammonium salts of herbicides bearing acidic moieties and their use as herbicides
02/14/2002WO2001070671A3 Insecticidal anthranilamides
02/14/2002WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
02/14/2002US20020019412 Antidiabetic agents
02/14/2002US20020019408 New isoxazole-sulfonamide endothelin antagonists
02/14/2002US20020019401 Psychological disorders; adjustment of dopamine concentration
02/14/2002US20020017297 Dry powder dispersing apparatus and methods for their use
02/14/2002DE10036184A1 Substituierte Sulfonylaminomethylbenzoesäure(derivate) und Verfahren zu ihrer Herstellung Substituted Sulfonylaminomethylbenzoesäure (derivatives) and processes for their preparation
02/14/2002CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/14/2002CA2419030A1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
02/14/2002CA2419027A1 Bicyclic compounds as h3 receptor ligands
02/14/2002CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/13/2002EP1179032A1 Nucleators for crystallizable thermoplastic polymers
02/13/2002EP1178987A1 Substituted benzoylisoxazoles and the use thereof as herbicides
02/13/2002EP1178971A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
02/13/2002EP1178970A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants
02/13/2002EP1178958A2 N-cyanomethyl amides as protease inhibitors
02/13/2002CN1335839A Bis-sulfonamides
02/13/2002CN1335838A Pyrimidine compounds
02/13/2002CN1335778A Inhibitors against vascular lipid deposition containing chymase-inhibiting substances
02/13/2002CN1335307A Synthesis process of 2-amino quinbolone compounds
02/12/2002US6346620 Methods for preparation of 2-(4-(4-(4,5-dichloro-2-methylimidazol-1-yl)butyl)-1-piperazinyl)-5-fluoropyrimidine and salts thereof
02/12/2002US6346532 Antidiabetic, antilipemic, and hypoglycemic agents; adrenergic stimulants
02/12/2002CA2053705C Piperazine derivatives
02/07/2002WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/07/2002WO2002009648A2 Antimicrobial biaryl compounds
02/07/2002WO2001085700A3 Hiv replication inhibiting pyrimidines and triazines
02/07/2002WO2001074787A3 Crystalline pharmaceutical
02/07/2002US20020016492 Process for preparing 3-hydroxymethyl-4-(aryl or heterocyclic)-cyclopentanones
02/07/2002US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics
02/07/2002US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc.
02/07/2002US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha
02/07/2002US20020016328 Corticotropin releasing factor antagonists
02/07/2002US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use
02/07/2002US20020016297 4-oxo-2- ureido-1,4,5,6,-tetrahydro-pyrimidine derivatives
02/07/2002US20020015915 Azo compound containing metal and optical recording medium using the compound
02/07/2002US20020015805 Fluoro-substituted alkenyl compounds, liquid crystal compositions, and liquid crystal display elements
02/07/2002DE10037149A1 Substituierte Arylketone Substituted aryl ketones
02/07/2002CA2418121A1 Antimicrobial biaryl compounds
02/07/2002CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor
02/06/2002EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides
02/06/2002EP1177792A2 Dopamine D4 Ligands for the treatment of novelty-seeking disorders
02/06/2002EP1177195A1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
02/06/2002EP1177193A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds
02/06/2002EP1177190A2 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
02/06/2002EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands
02/06/2002EP1177176A1 Tri-aryl acid derivatives as ppar receptor ligands
02/06/2002EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
02/06/2002EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists